Advanced Filters
noise

Immune Thrombocytopenic Purpura Clinical Trials

A listing of Immune Thrombocytopenic Purpura medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 122 clinical trials
D Daiveek G Pattanashetty, MD

Cognitive Enhancement in Unipolar Depression With Yoga

It is evident from recent studies that cognitive deficits persist even after remission of depressive episode. Hence, in this study, the investigators would like to see whether specific Yoga practice will help in enhancing cognitive abilities in this population.

18 - 60 years of age All Phase N/A

Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia

Evaluation effectiveness and safety of TMS in subjects with catatonia

18 - 35 years of age All Phase N/A
J Jasper O. Nuninga, Dr.

Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine

The goal of this clinical trial is to test the beneficial effects of rivastigmine administration, and predict the treatment outcome with electroencephalography (EEG), in patients with severe depression treated with electroconvulsive therapy (ECT). The study has two main objectives: to study whether rivastigmine would ameliorate the side-effect profile of ECT …

18 years of age All Phase 4
S Sarah Siddiqi

Depressed Mood Improvement Through Nicotine Dosing 3

Deficits in cognitive control are core features of late-life depression (LLD), contributing both to emotion dysregulation and problems with inhibiting irrelevant information, conflict detection, and working memory. Clinically characterized as executive dysfunction, these deficits are associated with poor response to antidepressants and higher levels of disability. Improvement of cognitive control …

60 years of age All Phase 2
M Mu-N Liu, PhD

Transcranial Direct Current Stimulation for Depression

Several studies have shown that tDCS is valuable and safe options to improve depressive symptoms in adult patients . However, regarding the tDCS to treat depression in elderly population, only few studies have been reported, and there is no consensus among them. To our knowledge, prefrontal cortex tDCS could be …

60 years of age All Phase N/A
N Nils I Landrø, PhD

Combining Antidepressants and Attention Bias Modification in Depression

Background: Major depressive disorder (MDD) is a highly prevalent psychiatric condition associated with significant disability, mortality and economic burden. A large proportion of MDD patients are treated in primary health care (PHC) in the municipalities and represent a challenging group. Attentional Bias Modification (ABM) training in combination with antidepressants (SSRIs) …

18 - 65 years of age All Phase N/A
S Sarah Siddiqi

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

Deficits in cognitive control are core features of late-life depression (LLD), contributing both to emotion dysregulation and problems with inhibiting irrelevant information, conflict detection, and working memory. Clinically characterized as executive dysfunction, these deficits are associated with poor response to antidepressants and higher levels of disability. Improvement of cognitive control …

60 years of age All Phase 2
H Huang Manli

Augmentation of Interpersonal Psychotherapy With High-Definition Transcranial Direct Current Stimulation for Adolescent Depression

Depression is among the most prevalent psychiatric disorders, with an upward trend in its manifestation in younger individuals. In contrast to adult depression, adolescent depression often presents with longer attack durations, higher recurrence rates, chronicity, and elevated disability rates. At present, treatment options for adolescent depression encompass pharmacological, physical, and …

12 - 18 years of age All Phase N/A
F Francisney P Nascimento, 1

Administration of Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression: a Randomized Double-blind Controlled Clinical Trial - COGUNILA

Major Depressive Disorder is a chronic mental health condition that affects the quality of life and occupational capacity of over 300 million people worldwide, including 11 million in Brazil alone, making it the second most depressive country in the Americas. Despite advances in understanding the pathophysiological mechanisms of depression, many …

25 - 65 years of age All Phase 1/2
A Anne M Myhre, MD phd

Music Therapy for Adolescents with Emotional Difficulties

The goal of this clinical trial is to examine the effects of a music therapy program in adolescents aged 13-18 years old with emotional difficulties, primarily depression and possibly concurrent diagnoses of anxiety. The main questions are: What recruitment methods, barriers, and facilitators influence study participation among adolescents with emotional …

13 - 18 years of age All Phase N/A

Simplify language using AI